BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21328602)

  • 1. An overview of techniques for linking high-dimensional molecular data to time-to-event endpoints by risk prediction models.
    Binder H; Porzelius C; Schumacher M
    Biom J; 2011 Mar; 53(2):170-89. PubMed ID: 21328602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosting for high-dimensional time-to-event data with competing risks.
    Binder H; Allignol A; Schumacher M; Beyersmann J
    Bioinformatics; 2009 Apr; 25(7):890-6. PubMed ID: 19244389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data.
    Gui J; Li H
    Bioinformatics; 2005 Jul; 21(13):3001-8. PubMed ID: 15814556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of survival prediction models based on microarray data.
    Schumacher M; Binder H; Gerds T
    Bioinformatics; 2007 Jul; 23(14):1768-74. PubMed ID: 17485430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupled variable selection for regression modeling of complex treatment patterns in a clinical cancer registry.
    Schmidtmann I; Elsäßer A; Weinmann A; Binder H
    Stat Med; 2014 Dec; 33(30):5358-70. PubMed ID: 25345575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial Cox regression analysis for high-dimensional microarray gene expression data.
    Li H; Gui J
    Bioinformatics; 2004 Aug; 20 Suppl 1():i208-15. PubMed ID: 15262801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited.
    Segal MR
    Biostatistics; 2006 Apr; 7(2):268-85. PubMed ID: 16284340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allowing for mandatory covariates in boosting estimation of sparse high-dimensional survival models.
    Binder H; Schumacher M
    BMC Bioinformatics; 2008 Jan; 9():14. PubMed ID: 18186927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting proportional hazards models using smoothing splines, with applications to high-dimensional microarray data.
    Li H; Luan Y
    Bioinformatics; 2005 May; 21(10):2403-9. PubMed ID: 15713732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting method for nonlinear transformation models with censored survival data.
    Lu W; Li L
    Biostatistics; 2008 Oct; 9(4):658-67. PubMed ID: 18344565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapting prediction error estimates for biased complexity selection in high-dimensional bootstrap samples.
    Binder H; Schumacher M
    Stat Appl Genet Mol Biol; 2008; 7(1):Article12. PubMed ID: 18384265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of resampling methods for assessment of survival risk prediction in high-dimensional settings.
    Subramanian J; Simon R
    Stat Med; 2011 Mar; 30(6):642-53. PubMed ID: 21337359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging external knowledge on molecular interactions in classification methods for risk prediction of patients.
    Porzelius C; Johannes M; Binder H; Beissbarth T
    Biom J; 2011 Mar; 53(2):190-201. PubMed ID: 21328603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dimensional Cox models: the choice of penalty as part of the model building process.
    Benner A; Zucknick M; Hielscher T; Ittrich C; Mansmann U
    Biom J; 2010 Feb; 52(1):50-69. PubMed ID: 20166132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search.
    Zhou X; Wang H; Wang J; Wang Y; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Chang SF; Wong ST
    Proteomics; 2009 Apr; 9(8):2286-94. PubMed ID: 19337989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Support vector methods for survival analysis: a comparison between ranking and regression approaches.
    Van Belle V; Pelckmans K; Van Huffel S; Suykens JA
    Artif Intell Med; 2011 Oct; 53(2):107-18. PubMed ID: 21821401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partly conditional survival models for longitudinal data.
    Zheng Y; Heagerty PJ
    Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive risk models for survival data with high-dimensional covariates.
    Ma S; Kosorok MR; Fine JP
    Biometrics; 2006 Mar; 62(1):202-10. PubMed ID: 16542247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic biomarkers in diffuse large B-cell lymphoma.
    Lossos IS; Morgensztern D
    J Clin Oncol; 2006 Feb; 24(6):995-1007. PubMed ID: 16418498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.